Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 2, 2014, Pages 239-246

  Brown, Jeremiah R ^a   Katz, Ronit ^b   Ix, Joachim H ^b   de Boer, Ian H ^b   Siscovick, David S ^b   Grams, Morgan E ^b   Shlipak, Michael ^b   Sarnak, Mark J ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY INJURY; AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HOSPITALIZATION; HUMANS; INDEPENDENT LIVING; KIDNEY; LONGITUDINAL STUDIES; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84893609446     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05830513     Document Type: Article

References (29)

1. US Renal Data System: 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Minneapolis, MN, US Renal Data System, 2012
2. Grams ME, Astor BC, Bash LD, Matsushita K, Wang Y, Coresh J: Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury. J Am Soc Nephrol 21: 1757-1764, 2010
3. James MT, Hemmelgarn BR, Wiebe N, Pannu N, Manns BJ, Klarenbach SW, Tonelli M; Alberta Kidney Disease Network: Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: A cohort study. Lancet 376: 2096-2103, 2010
4. Tomlinson LA, Riding AM, Payne RA, Abel GA, Tomson CR, Wilkinson IB, Roland MO, Chaudhry AN: The accuracy of diagnostic coding for acute kidney injury in England-a single centre study. BMC Nephrol 14: 58, 2013
5. Mittalhenkle A, Stehman-Breen CO, Shlipak MG, Fried LF, Katz R, Young BA, Seliger S, Gillen D, Newman AB, Psaty BM, Siscovick D: Cardiovascular risk factors and incident acute renal failure in older adults: The Cardiovascular Health Study. Clin J Am Soc Nephrol 3: 450-456, 2008
6. Isakova T, Xie H, YangW, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305: 2432-2439, 2011
7. Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG: Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol 60: 200-207, 2012
8. Dominguez JR, Shlipak MG, Whooley MA, Ix JH: Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J AmSoc Nephrol 24: 647-654, 2013
9. Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S, Stern L: FGF-23 levels in patients with AKI and risk of adverse outcomes. Clin J Am Soc Nephrol 7: 1217-1223, 2012
10. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012
11. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, De Boer I, PalmasW, Siscovick D, Levey AS, Shlipak MG: Cystatin C identifies chronic kidney disease patients at higher risk for complications. J AmSoc Nephrol 22: 147-155, 2011
12. Shastri S, Katz R, ShlipakMG, KestenbaumB, Peralta CA, Kramer H, JacobsDR Jr, de Boer IH, Cushman M, SiscovickD, Sarnak MJ: Cystatin C and albuminuria as risk factors for development of CKD stage 3: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 57: 832-840, 2011
13. ShlipakMG, Coca SG, Wang Z, Devarajan P, Koyner JL, PatelUD, Thiessen-Philbrook H, Garg AX, Parikh CR; TRIBE-AKI Consortium: Presurgical serumcystatin C and risk of acute kidney injury after cardiac surgery. Am J Kidney Dis 58: 366-373, 2011
14. ShlipakMG, SarnakMJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: 2049-2060, 2005
15. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV: Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 1: 200-208, 2008
16. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium: Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93-104, 2011
17. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP, Wiler PG: The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1: 263-276, 1991
18. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 3: 358-366, 1993
19. Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL: Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J AmSoc Nephrol 17: 1688-1694, 2006
20. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H: Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. NEngl J Med 348: 1656-1663, 2003
21. Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer IH, Siscovick DS, Shlipak MG, Sarnak MJ: Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 25: 1560-1567, 2010
22. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004
23. Shlipak MG, Katz R, Cushman M, Sarnak MJ, Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A, Fried L: Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 118: 1416, 2005
24. Schoppet M, Hofbauer LC, Brinskelle-Schmal N, Varennes A, Goudable J, Richard M, Hawa G, Chapurlat R, Szulc P: Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: The STRAMBO study. J Clin Endocrinol Metab 97: E575-E583, 2012
25. Kendrick J, Cheung AK, Kaufman JS, Greene T, RobertsWL, Smits G, Chonchol M; HOST Investigators: FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 22: 1913-1922, 2011
26. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John SuttonM, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro OM, Kusek JW, Keane MG, Wolf M: FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408, 2011
27. Wolf M: Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21: 1427-1435, 2010
28. Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H: Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 84: 776-785, 2013
29. Witte EC, Lambers Heerspink HJ, de ZeeuwD, Bakker SJ, de Jong PE, Gansevoort R: Firstmorning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol 20: 436-443, 2009